In 2014 we defined our strategy for 2015-2020. In the coming years KNCV will work towards achieving its mission of eliminating TB in three focus areas: access, evidence and supportive systems.
The access focus area encompasses the deliverables needed to alleviate suffering, prevent deaths, and curb the epidemic by reducing transmission of drug-susceptible and drug-resistant TB. Here KNCV’s strategic objective is to improve access to early TB prevention and quality care for patients with all forms of tuberculosis, and achieve better individual outcomes and public health impact. This objective puts access to prevention and care at the center of our efforts to eliminate TB, acknowledging the profound disparities (socio-economic, co-morbidities, living and working conditions) that exist with regard to risk for TB and access to quality care. It also acknowledges the importance of smear-negative and extra-pulmonary TB, pediatric TB and drug-resistant forms of the disease, in addition to adult, drug-susceptible smear-positive pulmonary TB that has historically been the focus of National TB Programs. We have defined four key result areas (prevention of transmission, prevention of progression from infection to disease, early diagnosis and effective treatment of TB disease and overcoming barriers for special patient groups) covering the entire chain of TB control that needs to be addressed in order to achieve our mission.
The evidence focus area supports KNCV’s mission by providing the knowledge required to maximize the outputs and outcomes to improve access. The strategic objective here is to generate a solid evidence base for new and existing tools and interventions. This objective responds to the need for new interventions and approaches for TB control and the opportunities offered by technological innovations, while acknowledging the importance of producing the evidence to support their scale-up. It aims to identify in a methodologically rigorous way the most effective means (diagnostics, drugs, potentially vaccines) and interventions, as well as the target populations and modes of delivery with an optimal value for money. The key results areas for this objective include evaluation of new interventions (implementation research), optimizing performance of TB programs (operational research), and quantifying the problem to be addressed and identifying target populations (population epidemiology), as well as building the capacity to plan and conduct these types of research.
The supportive systems focus area further supports KNCV’s mission by optimizing the conditions for realizing the outputs and outcomes to improve access. The strategic objective is to support management systems that ensure efficient use of human and financial resources. It acknowledges that maximizing equitable access requires technological and managerial solutions that take a holistic view of TB control as being embedded in health systems and supported by various actors. The key result areas to reach this objective are strategic and include: operational planning for national TB control efforts, mobilizing resources for TB control (at the country level as well as globally), engagement and coordination of other sectors and partners (including the private sector, for example), and monitoring and evaluation of the outputs, outcomes and impact of TB control activities.
In each of these there focus areas KNCV will achieve its results through three types of activities: technical assistance, knowledge center functions, and policy dialogue and advocacy.
KNCV will offer technical assistance through an effective mix of long term in-country technical assistance and short term consultancies by highly specialized experts. We will build local capacity through local offices and country teams, while ensuring that the latest developments are shared.
KNCV aims to be a knowledge center by generating, sharing and applying experiences, expertise and evidence for TB control. We will gather experiences with various approaches through our assistance work in countries, share these as best practices with clients, partners and policy makers, and apply them in other countries where we work. We will build expertise in assessments and studies that we will share in policy arenas and trainings, and apply them to develop new effective ways to control TB. The evidence we generate in our research projects will be shared through scientific publications, conferences and policy briefs, and of course will guide our interventions.
Finally, KNCV will be actively engaged in policy dialogue and advocacy, both at the country level and internationally. We will call on all of our experience, expertise and evidence to help generate policy recommendations and guidelines for various aspects of TB control, to share the policy insights, and to build the political support among governments, multilateral organizations and donors by informing and shaping policy dialogue and advocacy towards effective TB control with the required policies, legislation and finance.